---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-049852"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2021-10-01T23:59:59+00:00"
generated_at: "2026-06-29T00:08:43.332270+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD EVP Operations Edward Borkowski departs effective Sept 30, 2021

## Summary
- Mr. Borkowski and company mutually agreed to separation; departure effective September 30, 2021.
- Separation treated as 'Good Reason' under Oct 2019 employment agreement; eligible for contractual severance benefits.
- No successor named; responsibilities reassigned among remaining executives.

## SEC filing metadata
- accession: 0001564590-21-049852
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2021-10-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/0001564590-21-049852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/txmd-8k_20210930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-049852
- JSON: https://secwatch.observer/filing/0001564590-21-049852.json
- Plain text: https://secwatch.observer/filing/0001564590-21-049852.txt

## Key facts
- Executive change
  Edward Borkowski departed as Executive Vice President, Operations at TherapeuticsMD, Inc..
  - Action: separated
  - Role: Executive Vice President, Operations
  source text: On September 30, 2021, TherapeuticsMD, Inc., a Nevada corporation (the “Company”), and Mr. Edward Borkowski, Executive Vice President, Operations of the Company, mutually agreed that Mr. Borkowski would separate from the Company, effective as of such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/0001564590-21-049852-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.